{"id":58096,"date":"2023-09-22T16:01:38","date_gmt":"2023-09-22T14:01:38","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/usmi-to-debut-the-canady-robotic-ai-surgical-system-at-the-first-global-surgical-oncology-summit-jerusalem-israel-january-2024\/"},"modified":"2023-09-22T16:01:38","modified_gmt":"2023-09-22T14:01:38","slug":"usmi-to-debut-the-canady-robotic-ai-surgical-system-at-the-first-global-surgical-oncology-summit-jerusalem-israel-january-2024","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/usmi-to-debut-the-canady-robotic-ai-surgical-system-at-the-first-global-surgical-oncology-summit-jerusalem-israel-january-2024\/","title":{"rendered":"USMI to Debut the Canady Robotic AI Surgical System at the First Global Surgical Oncology Summit Jerusalem, Israel January 2024"},"content":{"rendered":"
\n

TAKOMA PARK, Md.–(BUSINESS WIRE)–#USMI<\/a>–The Jerome Canady Research Institute for Advanced and Biological Technological Sciences (JCRI-ABTS) and US Medical Innovations, LLC (USMI) are pleased to announce today a ground-breaking achievement in surgical and robotic technology. The Canady Robotic AI Surgical System is the world\u2019s first AI robotic system that delivers cold atmospheric plasma (CAP) which is a three-dimensional non-contact bioelectric pulse electromagnetic field.<\/b> CAP selectively targets and kills microscopic tumor cells during surgery without damaging non-cancerous surrounding tissue. Despite advancements in surgery, chemotherapy, radiation, immunotherapy and biologic targeted therapy regimes, microscopic residual disease (5% to 65%) can still persist which contributes to local regional recurrence and poor survival. The Canady Robotic AI Surgical System will be displayed at the First Global Surgical Oncology Summit in Jerusalem, Israel (January 30 to February 2, 2024).<\/p>\n

<\/a>
<\/a>
<\/a>
<\/a><\/p>\n

\nThe Canady Robotic AI Surgical System\u2019s key components are a Motorized Positioning Arm, Speech Recognition Canady Electrosurgical Generator known as ORLI\u2122, Controller for CAP Devices, Robotic Assisted End Effectors which can be used in Open, Laparoscopic, Thoracoscopic, Endoscopic and Mini-invasive surgical procedures. The System also provides the surgeon with 10 degrees of freedom, Speech activation of the Robotic movements, AI Powered Software Programs, 3D Navigational Guided Surgical Planning, Advance Contour Tracking of the CAP Beam, Pre-Programmed CAP Dosimetry data for selectively targeting 32 Cancer cell types and a compact mobile design.<\/p>\n

\nJCRI-ABTS has been granted 5 key U.S. Patents: Application of delivering CAP technology to selectively target cancer cells at the surgical margin, Integrated Cold Plasma and High Frequency Electrosurgical System and Method for the Use and Treatment Therapy, Cold Plasma Robotic Delivery System by incorporating AI-enabled Speech Recognition, Pre-programed Dosimetry Data and Protocols for combined care such as chemotherapy, radiation, and surgery. These achievements signify a significant leap forward in the integration of robotics and artificial intelligence during surgical procedures.<\/p>\n

\nTaisen Zhuang, PhD, Chief Technology Officer stated, \u201cThe Canady Robotic AI Surgical System sets a new precedent for Robotic Cancer Surgery by combining AI Technology and CAP. This innovation sets a higher standard by enhancing accuracy, precision, and safety in the OR.\u201d<\/p>\n

\nSaravana Murthy, PhD, Vice President of Research added, \u201cThis smart integrated \u201cSystem\u201d represents the world\u2019s first therapy designed to selectively eliminate microscopic tumor cells at the surgical margins.\u201d<\/p>\n

\nJerome Canady, MD, FACS, CEO and Surgical Oncologist stated, \u201cThis technology will transform the landscape of the OR. ORLI\u2122 is a user-friendly system controlling the entire integrated SMART Operating Room. The platform will serve as a SIRI, ALEXA, and GOOGLE HOME for the operating room. Data collected from our recent FDA Phase 1 Clinical Trial on Stage 4 Cancer Patients combined with ten years of in-vitro translational molecular research data have been imported into the Canady Robotic AI Surgical System. This achievement signifies a significant leap forward integrating artificial intelligence and robotics in surgery. I would like to express my gratitude to our Engineers and Scientist for their role in achieving this revolutionary milestone.\u201d<\/p>\n

\nAbout JCRI-ABTS<\/b><\/p>\n

\nJCRI-ABTS is a state-of-the-art BSL 2 Translational Molecular Research Institute focusing on Plasma Oncotherapeutics (a new cancer treatment modality) using Cold Atmospheric Plasma to investigate and selectively treat cancer without damaging normal tissue.<\/p>\n

\nAbout US Medical Innovations<\/b><\/p>\n

\nUS Medical Innovations, LLC (USMI), based out of Takoma Park, MD, is a privately held FDA registered life science, biomedical and robotic device company. USMI is dedicated to expanding the boundaries of plasma medicine by pioneering new technologies for the development of state-of-the-art medical devices that advance patient outcomes and improve human lives.<\/p>\n

Contacts<\/b> <\/p>\n

\nKenniah Chestnut, Esq
\n
6930 Carroll Ave.
\n
Takoma Park, MD 20912
\n
301-270-0147 \/ KChestnut@usmedinnov.com<\/a>
www.usmedinnovations.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

TAKOMA PARK, Md.–(BUSINESS WIRE)–#USMI–The Jerome Canady Research Institute for Advanced and Biological Technological Sciences (JCRI-ABTS) and US Medical Innovations, LLC (USMI) are pleased to announce today a ground-breaking achievement in surgical and robotic technology. The Canady Robotic AI Surgical System is the world\u2019s first AI robotic system that delivers cold atmospheric plasma (CAP) which is … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-58096","6":"format-standard","7":"category-industry"},"yoast_head":"\nUSMI to Debut the Canady Robotic AI Surgical System at the First Global Surgical Oncology Summit Jerusalem, Israel January 2024 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/usmi-to-debut-the-canady-robotic-ai-surgical-system-at-the-first-global-surgical-oncology-summit-jerusalem-israel-january-2024\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"USMI to Debut the Canady Robotic AI Surgical System at the First Global Surgical Oncology Summit Jerusalem, Israel January 2024 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"TAKOMA PARK, Md.–(BUSINESS WIRE)–#USMI–The Jerome Canady Research Institute for Advanced and Biological Technological Sciences (JCRI-ABTS) and US Medical Innovations, LLC (USMI) are pleased to announce today a ground-breaking achievement in surgical and robotic technology. The Canady Robotic AI Surgical System is the world\u2019s first AI robotic system that delivers cold atmospheric plasma (CAP) which is ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/usmi-to-debut-the-canady-robotic-ai-surgical-system-at-the-first-global-surgical-oncology-summit-jerusalem-israel-january-2024\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-09-22T14:01:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230922283953\/en\/1896972\/21\/Final_robot_and_beam.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/usmi-to-debut-the-canady-robotic-ai-surgical-system-at-the-first-global-surgical-oncology-summit-jerusalem-israel-january-2024\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/usmi-to-debut-the-canady-robotic-ai-surgical-system-at-the-first-global-surgical-oncology-summit-jerusalem-israel-january-2024\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"USMI to Debut the Canady Robotic AI Surgical System at the First Global Surgical Oncology Summit Jerusalem, Israel January 2024\",\"datePublished\":\"2023-09-22T14:01:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/usmi-to-debut-the-canady-robotic-ai-surgical-system-at-the-first-global-surgical-oncology-summit-jerusalem-israel-january-2024\\\/\"},\"wordCount\":612,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/usmi-to-debut-the-canady-robotic-ai-surgical-system-at-the-first-global-surgical-oncology-summit-jerusalem-israel-january-2024\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230922283953\\\/en\\\/1896972\\\/21\\\/Final_robot_and_beam.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/usmi-to-debut-the-canady-robotic-ai-surgical-system-at-the-first-global-surgical-oncology-summit-jerusalem-israel-january-2024\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/usmi-to-debut-the-canady-robotic-ai-surgical-system-at-the-first-global-surgical-oncology-summit-jerusalem-israel-january-2024\\\/\",\"name\":\"USMI to Debut the Canady Robotic AI Surgical System at the First Global Surgical Oncology Summit Jerusalem, Israel January 2024 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/usmi-to-debut-the-canady-robotic-ai-surgical-system-at-the-first-global-surgical-oncology-summit-jerusalem-israel-january-2024\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/usmi-to-debut-the-canady-robotic-ai-surgical-system-at-the-first-global-surgical-oncology-summit-jerusalem-israel-january-2024\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230922283953\\\/en\\\/1896972\\\/21\\\/Final_robot_and_beam.jpg\",\"datePublished\":\"2023-09-22T14:01:38+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/usmi-to-debut-the-canady-robotic-ai-surgical-system-at-the-first-global-surgical-oncology-summit-jerusalem-israel-january-2024\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/usmi-to-debut-the-canady-robotic-ai-surgical-system-at-the-first-global-surgical-oncology-summit-jerusalem-israel-january-2024\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/usmi-to-debut-the-canady-robotic-ai-surgical-system-at-the-first-global-surgical-oncology-summit-jerusalem-israel-january-2024\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230922283953\\\/en\\\/1896972\\\/21\\\/Final_robot_and_beam.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230922283953\\\/en\\\/1896972\\\/21\\\/Final_robot_and_beam.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/usmi-to-debut-the-canady-robotic-ai-surgical-system-at-the-first-global-surgical-oncology-summit-jerusalem-israel-january-2024\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"USMI to Debut the Canady Robotic AI Surgical System at the First Global Surgical Oncology Summit Jerusalem, Israel January 2024\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"USMI to Debut the Canady Robotic AI Surgical System at the First Global Surgical Oncology Summit Jerusalem, Israel January 2024 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/usmi-to-debut-the-canady-robotic-ai-surgical-system-at-the-first-global-surgical-oncology-summit-jerusalem-israel-january-2024\/","og_locale":"en_US","og_type":"article","og_title":"USMI to Debut the Canady Robotic AI Surgical System at the First Global Surgical Oncology Summit Jerusalem, Israel January 2024 - Pharma Trend","og_description":"TAKOMA PARK, Md.–(BUSINESS WIRE)–#USMI–The Jerome Canady Research Institute for Advanced and Biological Technological Sciences (JCRI-ABTS) and US Medical Innovations, LLC (USMI) are pleased to announce today a ground-breaking achievement in surgical and robotic technology. The Canady Robotic AI Surgical System is the world\u2019s first AI robotic system that delivers cold atmospheric plasma (CAP) which is ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/usmi-to-debut-the-canady-robotic-ai-surgical-system-at-the-first-global-surgical-oncology-summit-jerusalem-israel-january-2024\/","og_site_name":"Pharma Trend","article_published_time":"2023-09-22T14:01:38+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230922283953\/en\/1896972\/21\/Final_robot_and_beam.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/usmi-to-debut-the-canady-robotic-ai-surgical-system-at-the-first-global-surgical-oncology-summit-jerusalem-israel-january-2024\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/usmi-to-debut-the-canady-robotic-ai-surgical-system-at-the-first-global-surgical-oncology-summit-jerusalem-israel-january-2024\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"USMI to Debut the Canady Robotic AI Surgical System at the First Global Surgical Oncology Summit Jerusalem, Israel January 2024","datePublished":"2023-09-22T14:01:38+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/usmi-to-debut-the-canady-robotic-ai-surgical-system-at-the-first-global-surgical-oncology-summit-jerusalem-israel-january-2024\/"},"wordCount":612,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/usmi-to-debut-the-canady-robotic-ai-surgical-system-at-the-first-global-surgical-oncology-summit-jerusalem-israel-january-2024\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230922283953\/en\/1896972\/21\/Final_robot_and_beam.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/usmi-to-debut-the-canady-robotic-ai-surgical-system-at-the-first-global-surgical-oncology-summit-jerusalem-israel-january-2024\/","url":"https:\/\/pharma-trend.com\/en\/usmi-to-debut-the-canady-robotic-ai-surgical-system-at-the-first-global-surgical-oncology-summit-jerusalem-israel-january-2024\/","name":"USMI to Debut the Canady Robotic AI Surgical System at the First Global Surgical Oncology Summit Jerusalem, Israel January 2024 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/usmi-to-debut-the-canady-robotic-ai-surgical-system-at-the-first-global-surgical-oncology-summit-jerusalem-israel-january-2024\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/usmi-to-debut-the-canady-robotic-ai-surgical-system-at-the-first-global-surgical-oncology-summit-jerusalem-israel-january-2024\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230922283953\/en\/1896972\/21\/Final_robot_and_beam.jpg","datePublished":"2023-09-22T14:01:38+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/usmi-to-debut-the-canady-robotic-ai-surgical-system-at-the-first-global-surgical-oncology-summit-jerusalem-israel-january-2024\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/usmi-to-debut-the-canady-robotic-ai-surgical-system-at-the-first-global-surgical-oncology-summit-jerusalem-israel-january-2024\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/usmi-to-debut-the-canady-robotic-ai-surgical-system-at-the-first-global-surgical-oncology-summit-jerusalem-israel-january-2024\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230922283953\/en\/1896972\/21\/Final_robot_and_beam.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230922283953\/en\/1896972\/21\/Final_robot_and_beam.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/usmi-to-debut-the-canady-robotic-ai-surgical-system-at-the-first-global-surgical-oncology-summit-jerusalem-israel-january-2024\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"USMI to Debut the Canady Robotic AI Surgical System at the First Global Surgical Oncology Summit Jerusalem, Israel January 2024"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/58096","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=58096"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/58096\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=58096"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=58096"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=58096"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}